Advances in the Diagnostic Role of Microbiota in Human Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Diagnostic Microbiology and Infectious Disease".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 27237
Special Issue Editor
Interests: cardiovascular diseases; metabolic diseases; diabetes; metabolism; insulin resistance; glucose metabolism; nutrition; fat; energy metabolism; inflammatory biomarkers; clinical nutrition; human microbiota
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It has recently become evident that many factors play pivotal roles in the diagnosis and management of systemic health. The human microbiota is a super organ in our body. When the microbiota is disrupted, which is called dysbiosis, the occurrence of diseases is then increased and management becomes complex. Metabolic patients with dysbiotic microbiota are most at risk for cardiovascular disease. Moreover, dysbiosis of the microbiota is also involved in many systemic diseases, such as diabetes, obesity, autoimmune rheumatic disease, and cancer. In this Special Issue, we will address the nature of the human microbiota and how it affects systemic pathologies with bidirectional interactions. Exploration of the human microbiota may be a key factor, and its diagnostic may contribute to chronic metabolic diseases or human diseases. The role of human microbiota (oral, gut, skin) is the next evolution for biology and medicine. We are also interested in future therapeutic strategies. The discovery of the implications of microbiota for the control of systemic diseases could represent a new method for personalized medicine.
Dr. Vincent Blasco-Baque
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.